Browse everything: Tickers A–Z · Issuers · Comparisons · Tags
CNTB Stock — Connect Biopharma Holdings Ltd
Connect Biopharma Holdings Ltd (CNTB)
Updated October 16, 2026.
CNTB is a Stock. Total return is -95.1% over the past 5.6 years, 206.0 points behind SPY at 110.9%.
Connect Biopharma Holdings Limited is a clinical-stage biopharmaceutical company headquartered in San Diego that develops rademikibart, a monoclonal antibody targeting IL-4Ra for potential treatment of acute asthma exacerbations and chronic obstructive pulmonary disease (COPD), currently in Phase 2 trials. The company does not currently pay distributions. This security may appeal to investors seeking exposure to early-stage drug development in respiratory and inflammatory disease treatment, though it carries the higher risk profile typical of pre-revenue biopharmaceutical companies.
CNTB performance versus SPY
Price and return data through 2026-10-16.
Total return is -95.1% over the past 5.6 years, 206.0 points behind SPY at 110.9%. Over the past year its total return — price change plus distributions reinvested — is -50.5%. Its deepest 1-year drawdown was 76.4%.
| Window | Total return | CAGR |
|---|---|---|
| 1M | -26.9% | — |
| 3M | -61.2% | — |
| 6M | -69.7% | — |
| YTD | -67.9% | — |
| 1Y | -50.5% | — |
| 2Y CAGR | — | -14.90% |
| 3Y CAGR | — | -3.90% |
| 5Y CAGR | — | -44.50% |
| Since inception (5.6 years) | -95.1% | -41.80% |
CNTB key facts
- Asset type
- Stock
- Asset class
- Equity
- Inception date
- 03/19/2021
- Distribution frequency
- None
- Last close
- $0.91 (as of 2026-10-16)
- Market cap
- $57,073,616
- Average volume
- 573129.0
- Beta
- -0.183
- Payout ratio
- 0.0%
- Forward P/E
- 0.7669
- EPS
- $-1.19
How Dividend Vision calculates yield and returns
Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.
Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology
Sources and review
Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.
Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.
CNTB risks and drawbacks
Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 76.4%.
Who may consider CNTB — and who may not
It is a weaker fit for investors who need monthly cash flow (CNTB does not currently distribute); investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.
More on CNTB
Frequently asked questions
Does CNTB pay monthly?
No. CNTB does not currently distribute.
When does CNTB pay a dividend?
CNTB does not currently distribute.
How has CNTB performed?
Total return is -95.1% over the past 5.6 years, 206.0 points behind SPY at 110.9%. Over the past year its total return — price change plus distributions reinvested — is -50.5%. Its deepest 1-year drawdown was 76.4%.
Tickers
Holdings as-of date unavailable.
| Ticker | Name | Weight |
|---|
See how this investment would fit into your portfolio.